CiRC Biosciences
Chicago
About CiRC Biosciences
CiRC Biosciences operates in the biotechnology industry, focusing on the development of potential cell therapy treatments. The company is currently in the pre-clinical development stage for a treatment for retinitis pigmentosa (RP) and dry age-related macular degeneration. These conditions are related to vision loss, and CiRC Biosciences is working on innovative solutions to address them. The company is a portfolio company of Paragon Biosciences.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $23.8M
- Last round: Debt Financing (May 2024)
- Website: circbiosciences.com
- Phone: 1 312 -847-1360
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/circ-biosciences-22831 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.